VC Funds Starting with A

Ascent Venture Partners is a Boston-based venture capital firm founded in 1985, making it one of the longest-established early-stage technology investors in the eastern United States. With $500 million in assets under management across five venture funds, Ascent has backed over 110 early-stage B2B technology companies since inception, generating more than $10 billion in enterprise value. The investment team is led by General Partners Luke Burns, Matt Fates, and Geoff Oblak, supported by CFO Tom Scanlon and a team of eight. The firm invests primarily in East Coast startups at pre-seed and seed stages, writing initial checks of $2 million to $5 million in enterprise SaaS, software, B2B platforms, cybersecurity, and data analytics. With 160 total investments and 78 exits, Ascent's track record spans nearly four decades of enterprise technology cycles — from client-server through cloud-native. The most recent investment was in Symx.Ai, a business and productivity software company, in June 2023. Ascent's four decades of institutional enterprise investing have produced something few early-stage funds can claim: a genuine alumni network of more than 100 portfolio companies whose founders and executives serve as ongoing references, co-investors, and advisors. The firm's approach combines early-stage conviction with board-level engagement from inception through exit, building partnerships that operate over the full arc of company development rather than just the initial funding event.

Asha Impact, founded in 2014 by Vikram Gandhi and Pramod Bhasin, is an impact investment platform based in New Delhi. It focuses on sectors that address key social challenges in India, such as financial inclusion, education, healthcare, agriculture, and clean energy. By blending venture capital with philanthropy, Asha Impact supports early-stage companies that deliver scalable solutions to these pressing issues. The firm is known for backing startups like Adda247, an edtech platform, and Truemeds, a healthcare company providing affordable medicine. Asha Impact typically invests in early and growth-stage businesses, often alongside other prominent venture capital firms. The platform’s approach emphasizes creating sustainable impact while also generating strong financial returns, working closely with its portfolio companies to guide their growth. Asha Impact is committed to fostering a more equitable future by empowering businesses that contribute to social and economic progress across India and other emerging markets.

Asia Venture Group (AVG) is a Kuala Lumpur, Malaysia-based internet holding company and venture capital firm founded in 2013 by Tim Marbach and Kai Kux. With approximately $100 million in assets under management, AVG focuses on long-term value creation in Southeast Asian digital markets by launching and investing in scalable online business models. The firm is deliberately selective, taking hands-on operational roles rather than passive equity positions — functioning as an active company builder embedded in portfolio operations. AVG has made 35 investments primarily at pre-seed and seed stages across e-commerce, fintech, food and beverage, healthtech, and digital marketing. The portfolio includes one unicorn — Cars24 — alongside iMoney, TrustedCompany, KFit, HappyFresh, and Limitless Technology, with 16 portfolio acquisitions recorded. The firm leads rounds and writes checks of $500K to $5 million. Tim Marbach previously served as Executive Chairman of TrustedCompany; Kai Kux co-founded HappyFresh, giving the partners direct operating experience in portfolio-adjacent categories. AVG's company-builder model distinguishes it from financial-only venture investors in the region: the team combines international operational know-how with deep local market relationships and the ability to recruit and manage local management talent on behalf of portfolio companies. This hands-on approach is particularly valuable in Southeast Asia, where market dynamics vary significantly by country and local execution is often the decisive competitive factor.

ASIF Ventures (Amsterdam Student Investment Fund) is a student-led venture capital fund based in Amsterdam, Netherlands, founded in 2017. Created by students who wanted to back young founders at a stage when traditional investors would not, ASIF supports startups founded by students and recent graduates of the University of Amsterdam (UvA) and Vrije Universiteit (VU). The fund provides €25K to €100K at the pre-seed stage — before minimum viable product and before revenue — along with network access and a community of early-stage entrepreneurs. ASIF operates a Scout Program to identify promising companies and is a formal partner of VU Entrepreneurship & Impact. With 25 portfolio companies supported since founding across software, SaaS, AI, and education sectors, ASIF leads rounds at the pre-seed stage and serves the Netherlands-focused early startup ecosystem. The fund connects portfolio companies to established venture capitalists, industry experts, and senior investors through its UvA and VU institutional relationships. ASIF Ventures is one of Europe's few student-run venture funds, and its dual mission is explicit: developing the next generation of founders alongside the next generation of venture investors. Team members gain hands-on investing experience — sourcing, evaluating, and supporting deals — while portfolio founders receive peer mentorship from people who understand the challenge of starting a company while completing a degree. This community-oriented model creates lasting professional relationships within the Amsterdam startup ecosystem.

Asimov Ventures is an early-stage venture capital firm with offices in New York City and Palo Alto. The firm focuses on investing in cutting-edge technologies such as 3D printing, robotics, and advanced computing. Asimov Ventures seeks to partner with visionary entrepreneurs dedicated to transforming their industries through innovative solutions. Notable investments by Asimov Ventures include Particle3D, which specializes in 3D-printed bone implants, and Kadena, a blockchain technology company. The firm also invests in various other sectors, including healthcare, e-commerce, and augmented reality, reflecting their broad interest in transformative technologies​. Asimov Ventures typically participates in funding rounds with other notable investors, providing capital and strategic support to help startups scale and succeed. Their investment strategy emphasizes early-stage companies with strong intellectual property and commercial potential​.

Aspect Ventures, founded in 2014 by Jennifer Fonstad and Theresia Gouw, is a leading venture capital firm based in Palo Alto, California. The firm focuses on early-stage investments, primarily in Series A rounds, across various sectors including cybersecurity, fintech, digital health, and enterprise software. Notable investments include Gusto, a cloud-based HR management platform; Chime, a digital bank; and Exabeam, a cybersecurity company. Aspect Ventures has had several successful exits such as Forescout Technologies, Imperva, and Trulia.

Assembly Climate Capital is a venture capital firm focused on driving significant climate impact through investments in businesses poised to address the challenges of climate change. The firm primarily invests in Series B and C companies that are ready for commercial deployment and scaling. Their investment philosophy centers on long-term, patient capital with an urgent focus on accelerating climate solutions within the next decade. Assembly Climate Capital brings together expertise in private equity, business strategy, and governance to support its portfolio companies. They emphasize real partnership, providing not just capital but also strategic guidance, mentorship, and access to a wide network of leaders and investors in the climate space. With over 40 years of experience across various sectors, the team is known for its strong track record in value creation and successful exits. Their portfolio includes a mix of climate-focused ventures like Tasman Environmental Markets and Future Super, which align with their mission to foster systemic change and help businesses achieve significant climate impact. Assembly Climate Capital also frequently co-invests with other family offices, further enhancing their collaborative approach to climate investing. Their goal is to support bold management teams in delivering transformative solutions to the most pressing environmental issues of our time.

Asset Management Ventures (AMV) is a Palo Alto-based venture capital firm founded in 1965 by Pitch Johnson, one of Amgen's co-founders — making it one of the longest continuously operating VC firms in Silicon Valley. The firm specializes in early-stage investments in digital health, technology, and life sciences, and raised its fifth and largest fund at $150 million in 2020. Partners Skip Fleshman and Lou Lange lead the current investment team, which combines scientific, engineering, and medical expertise with decades of investing experience. With 152 investments and 29 exits, AMV's historical portfolio includes Amgen itself, Tandem Computer, and Applied BioSystems — foundational companies in their respective industries. The current portfolio includes Reify Health, Evidation Health, Lark, Twist Bioscience (TWST), Freenome, Welldoc, ViewPoint Therapeutics, Aavia, and 3T Biosciences, reflecting AMV's sustained focus on health technology and life sciences innovation. The firm leads rounds and deploys $1 million to $15 million across seed through Series B stages. AMV's six-decade track record is its most distinctive asset: the firm has seen multiple complete technology and healthcare cycles, giving the investment team a depth of pattern recognition and investor network that newer funds cannot replicate. The founding connection to Amgen also provides an ongoing cultural orientation toward building enduring life sciences companies rather than optimizing for short-cycle exits — an orientation that informs how AMV partners with founders over the long arc of company development.

Astanor Ventures, founded in 2017 by Eric Archambeau and George Coelho, is a Brussels-based venture capital firm specializing in sustainable agrifood technologies. The firm focuses on investing in early-stage, mission-driven companies that address significant social or environmental issues within the agrifood value chain. This includes sectors like regenerative agriculture, bioeconomy, and climate-positive solutions. Astanor recently closed its second venture fund at €360 million, bringing its total assets under management to €800 million. This fund will support innovative solutions aimed at transforming the global food system to be more sustainable and resilient​. The firm boasts an extensive network of entrepreneurs, experts, scientists, and policymakers, which helps identify and nurture groundbreaking technologies. Notable investments include companies that advance autonomous electric agricultural machinery, high-functioning proteins, and genomic sequencing for sustainable food production.

Astarc Ventures, established in 2015, is the corporate venture arm of Astarc Group based in Mumbai, India. The fund focuses on early-stage investments in innovative technology companies across various sectors, including fintech, healthtech, logistics, AI/ML, and e-commerce. Notably, Astarc Ventures invests globally, with a presence in markets like India, Israel, the United States, and the United Kingdom. The firm typically supports entrepreneurs whose ventures align with Astarc Group's strategic interests and disruptive technologies. With over 60 investments, Astarc Ventures has backed companies such as Rooter, Purple Style Labs, Jai Kisan, and Dataloop. These investments span diverse industries from AI-driven solutions to consumer marketplaces and climate-tech. The firm is also known for its exits, including Liv.ai, which was acquired by Flipkart in 2018. Led by Executive Director Salil Musale and an experienced team, Astarc Ventures leverages deep operational expertise to help portfolio companies scale. The team takes an active role in guiding startups, offering both strategic advice and operational support, especially in emerging sectors.

Astarte Ventures is a Yardley, Pennsylvania-based venture capital fund founded in 2013 by Tracy Warren, recognized as the first venture fund dedicated exclusively to the health and wellbeing of women and children. As a first-mover in FemTech investing — well before the category had a name — Warren built a concentrated portfolio anchored in early intervention and prevention, spanning healthtech, life sciences, and technology sectors that improve outcomes for mothers, women, and children. Warren also serves as a mentor at Harvard's Wyss Institute. The fund has made eight investments at seed and Series A stages with checks of $500K to $3 million. Two outcomes define the portfolio's credibility: Maven Clinic, which became the largest virtual clinic for women's and family health and achieved unicorn status in 2021, and Alydia Health, acquired by Organon for $215 million in March 2021. These exits anchor the fund's FemTech track record against a backdrop of concentrated, conviction-led investing. Astarte Ventures' small portfolio size is intentional — Warren's model prioritizes deep engagement with each company over broad deployment. Each portfolio company benefits from Tracy Warren's domain expertise in female health outcomes and impact investing, as well as her network across academic medicine, women's health advocacy, and the broader healthcare industry. For founders in FemTech, backing from Astarte carries the credibility of the category's earliest and most dedicated institutional champion.

Astellas Venture Management (AVM) is the wholly-owned corporate venture capital arm of Astellas Pharma, one of the world's leading pharmaceutical companies. Founded in 2005 and headquartered in South San Francisco, AVM has provided equity investments to private, early-stage companies developing therapeutic programs and platform technologies for over twenty years. The investment thesis is explicitly strategic: AVM targets science that enhances the Astellas R&D pipeline or catalyzes new directions in discovery research, with the team's Pharma View serving as both a selection lens and a support framework. AVM has invested in 61 companies across 104 total investment rounds, deploying $3 million to $20 million per company at seed through Series B stages. Series A is the most active stage, with 19 investments averaging $33.8 million in round size. Notable current portfolio companies include Solu Therapeutics, Syntax Bio, PhoreMost, and Somite. The most recent investment was in Solu Therapeutics in April 2025, and the most recent exit was Orna Therapeutics in February 2026. A team of eight, including three partners and one principal, spans the US and Japan. AVM's principal value to portfolio companies is its deep pharmaceutical industry expertise and the pathway it opens to Astellas Pharma: strategic licensing dialogues, research collaborations, and potential acquisitions that purely financial investors cannot facilitate. For early-stage biotech founders, AVM's Pharma View means receiving guidance from investors who understand drug development not as outsiders but as participants in the global pharmaceutical system.

Aster Capital, established in 2000 and based in Paris, is a venture capital firm specializing in Climate Tech investments. The firm focuses on sectors such as energy, mobility, and industry, supporting startups at various stages of development. Aster Capital manages around €500 million in assets and operates globally with offices in Paris, San Francisco, and Tel Aviv. Key investments by Aster include companies like ekWateur, an energy supplier accelerating the energy transition; Betterway, a pioneer in employee mobility solutions; and Iceotope, specializing in liquid cooling technologies for data centers. These investments reflect Aster’s commitment to supporting innovative solutions that contribute to carbon neutrality. Aster recently raised €240 million to invest in energy transition and future mobility projects, underscoring their dedication to driving significant environmental impact through technology. The firm’s strategy involves not only financial investment but also providing extensive support through their "Business Hub" approach, which facilitates business opportunities and partnerships for their portfolio companies​.

Astera Institute is a venture capital fund dedicated to empowering visionary science and technology projects that can create transformative progress for human civilization. Founded by Jed McCaleb, the institute focuses on incubating high-leverage ideas at their earliest stages to effect systemic change through entrepreneurial experimentation. They invest in overlooked areas and support founders capable of initiating significant innovations, particularly in fields such as artificial general intelligence and open science​. Astera Capital, established in partnership with Flow Capital in 2020, operates as a hedge fund focused on fixed-income investments in Asia. Based in Hong Kong, Astera Capital aims to create value for its investors through strategic investments and an extensive network of industry relationships. The firm is committed to building a comprehensive alternative investment platform, leveraging the expertise of its experienced investment team to navigate complex financial markets​.

Astor Perkins is a New York-based venture capital firm focused exclusively on deep tech and human survival sectors. Established in 2020, the firm invests in cutting-edge technologies that address some of the most critical challenges humanity faces, both on Earth and in space. Its key areas of interest include space exploration, terraforming, plant-based foods, clean energy, longevity, AI, robotics, and quantum computing. Astor Perkins collaborates with global leaders aiming to build future cities, tackle climate change, and enhance human health and survival. The firm has been involved in notable investments such as D-Orbit, Bloom Diagnostics, and Lunar Station, backing companies at various stages of development. With its deep expertise, the fund prides itself on providing strategic, mission-critical advice that drives impactful innovations. Led by Scott Amyx, a recognized authority in emerging technologies, Astor Perkins is a major player in pushing the boundaries of deep tech, from AI to space technologies.

AstraZeneca is a leading global biopharmaceutical company with a strong focus on oncology, biopharmaceuticals, and rare diseases. They are committed to discovering, developing, and delivering innovative medicines that transform the lives of patients worldwide. AstraZeneca's oncology portfolio is particularly noteworthy, with a significant emphasis on creating groundbreaking cancer treatments. Their strategy includes leveraging various scientific platforms such as antibody-drug conjugates (ADCs), radioconjugates, and T cell engagers. Recent high-profile deals include collaborations with Daiichi Sankyo for ADCs and the acquisition of Neogene Therapeutics to enhance their T cell receptor therapy capabilities​​. In addition to oncology, AstraZeneca has a robust pipeline in biopharmaceuticals aimed at addressing chronic diseases and enhancing long-term health outcomes. They are also advancing treatments for rare diseases, expanding their reach globally to ensure broader access to their innovative therapies​​. AstraZeneca's business development approach is integral to their growth, focusing on strategic alliances and partnerships. This includes collaborations with companies like Tempus for AI-enabled precision medicine and various biotech firms to accelerate advancements in areas like epigenetics and undruggable targets​​. The company emphasizes a culture of innovation, diversity, and sustainability, aiming to make a significant impact on global health while maintaining environmental responsibility through initiatives like Ambition Zero Carbon​.

Astutia Ventures is a Munich, Germany-based venture capital firm founded in 2006 by Benedict Rodenstock, focused on innovative European startups across three thematic areas: smart cities, the future of commerce, and digital lifestyle. The firm invests at seed and Series A stages, writing checks of $500K to $3 million, with a portfolio of 30 companies built over nearly two decades of active European investing. The team of four, including two partners, operates alongside an advisory practice — Astutia Advisory — that extends the firm's influence into venture capital consulting. Portfolio companies include Commercetools, a modern commerce infrastructure platform; Mister Spex, a leading European eyewear e-commerce company; Dreamlines, a cruise booking platform; Koloma, an energy company; and 99chairs, an interior design marketplace. The firm frequently co-invests with HTGF (High-Tech Gründerfonds) and other established European early-stage funds, indicating its position within the core Munich and broader German venture network. Astutia's thematic focus on smart cities, commerce, and lifestyle technology has proven durable over multiple market cycles, covering both consumer-facing and enterprise applications within European markets. Benedict Rodenstock's Munich business network gives portfolio companies access to the Bavarian industrial and commercial ecosystem — a geography that is both one of Europe's most economically productive and one of the less saturated by venture capital compared to Berlin or London. The firm's selective approach and deep regional roots produce a portfolio that is distinctive rather than generic.

Asymmetric Financial is a venture capital firm that focuses on investing in early-stage companies within the fintech, software, and digital health sectors. Founded by Joe McCann in 2022, the firm operates with a unique approach to venture capital, combining deep expertise in technology and finance to support companies that are poised to disrupt traditional industries. Asymmetric Financial aims to identify and back innovative startups that leverage advanced technologies such as artificial intelligence, blockchain, and big data analytics to create new market opportunities. The firm’s investment strategy is centered on providing not only capital but also strategic guidance and operational support. Asymmetric Financial works closely with its portfolio companies to help them scale efficiently, offering assistance in areas such as financial planning, go-to-market strategies, and key performance indicator (KPI) development. This hands-on approach ensures that the startups in their portfolio are well-equipped to navigate the challenges of rapid growth and market competition. Asymmetric Financial is particularly interested in companies that have the potential to generate significant returns while also creating meaningful impact through their innovations. By focusing on sectors that are at the intersection of technology and finance, the firm aims to contribute to the modernization and transformation of the financial services industry.

Asymmetric Capital Partners (ACP) is a venture capital firm focused on backing B2B technology companies from Seed to Series C stages. Founded in 2020 by Rob Biederman, former co-CEO of Catalant Technologies, ACP manages an oversubscribed debut fund of $105 million. The firm targets disruptive businesses in areas like healthcare IT, fintech, marketplaces, and next-gen software, especially those transforming legacy industries and capitalizing on digital innovation. ACP is known for its hands-on approach, leveraging a team of founders and former operators who work closely with startups on strategic growth areas such as hiring, go-to-market strategies, and financial planning. They typically invest between $2M to $10M, with the flexibility to co-invest in larger deals alongside top firms like Andreessen Horowitz and Sequoia Capital. Some notable investments include Firstbase, a remote work platform backed by Andreessen Horowitz, and Clearco, a fintech company. The firm prides itself on being deeply involved with its portfolio companies, providing both operational support and access to a vast network of advisors and industry experts.

Asymmetry Ventures, based in San Francisco, is a prominent early-stage venture capital firm founded by Rob Ness. The firm focuses on investing in transformative startups that have the potential to create significant impact. They have a diverse portfolio of over 280 investments, including notable companies like BillionToOne, Foresight Mental Health, Mast Reforestation (formerly DroneSeed), and Orbit Fab. Asymmetry Ventures is known for their commitment to supporting defensible businesses, particularly in sectors such as artificial intelligence, biotechnology, and aerospace. They typically make initial investments in the range of $2 million and have been involved in notable funding rounds such as Orbit Fab's $10 million raise, which also saw participation from major aerospace players like Northrop Grumman and Lockheed Martin. The firm prides itself on identifying and backing visionary founders and innovative business models, with a strong emphasis on early-stage investments that leverage technology to create natural barriers to entry and generate recurring revenue streams. They also prioritize investments that address significant market needs with scalable solutions. For startups looking to partner with Asymmetry Ventures, demonstrating a strong leadership team and a clear path to market dominance are crucial. The firm's deep network and extensive industry experience provide valuable support and guidance to their portfolio companies, enhancing their potential for growth and success.

AT Inc, now known as Amazon Catalytic Capital, is Amazon’s venture capital initiative with an initial commitment of $150 million aimed at supporting underrepresented founders. The fund invests in venture capital funds, accelerators, incubators, and venture studios that prioritize startups led by Black, Latino, Indigenous, women, and LGBTQIA+ entrepreneurs. This initiative not only provides financial backing but also offers mentorship from Amazon executives and access to resources that can aid in business and technical strategy. Key investments include Collide Capital, Elevate Future Fund, Share Ventures, and Techstars Rising Stars Fund. These funds focus on diverse founders working in areas such as clean energy, fintech, health tech, and consumer goods. Amazon’s goal is to foster inclusion and innovation, ultimately driving economic growth and creating generational wealth for historically underserved communities.

At One Ventures is a venture capital firm founded in 2020 by Tom Chi, a founding member of Google X. The firm is dedicated to investing in early-stage startups that are developing disruptive deep tech solutions aimed at making humanity a net positive to nature. With a strong focus on climate tech, At One Ventures has established itself as a significant player in the industry. The firm recently closed its second fund at $375 million, indicating strong investor confidence and a robust commitment to supporting climate-positive innovations. This fund follows their initial $150 million fund and aims to support startups that can dramatically reduce environmental footprints while upending established industrial economics. At One Ventures' investment portfolio includes companies across various sectors such as renewable energy, sustainable agriculture, and advanced materials. Notable investments include Noon Energy, which focuses on long-duration energy storage, and MightyFly, which is developing hybrid electric drone delivery systems. The firm's approach is hands-on, providing strategic guidance in talent acquisition, operations, marketing, IP strategy, and manufacturing. The team at At One Ventures consists of experienced professionals with backgrounds in physical sciences, engineering, manufacturing, and finance, ensuring a deep understanding of the technologies and markets they invest in. They operate globally, with a presence in San Francisco and London, and continue to seek partnerships with entrepreneurs, scientists, and investors who share their vision for a sustainable future.

at.inc/, originally founded in 2015 as Tank Hill Ventures, is a boutique seed-stage venture capital firm that partners with founders 'at incorporation,' backing startups at the earliest possible stage, sometimes as early as the idea phase, then providing continuity, capital and support throughout the venture journey. Operating across Silicon Valley and Israel, the firm leads seed rounds with conviction and concentrates on technology startups with disruptive business models, with top sectors in enterprise applications and enterprise infrastructure. Geographically its portfolio skews to the United States, around 60%, Israel, around 20%, and the United Kingdom, around 20%. The firm is led by Managing Partner Nadav Eylath, who has led seed investments in Netlify, Wescover, Disclosures.io, HoneyBook, Future Family, Opendoor (IPO) and Peer5 (acquired by Microsoft); General Partner Roni Bonjack brings operating experience having built and led global startup programs for Google and Facebook. After its first fund reportedly returned over 10x, the firm raised an oversubscribed $35M Fund II under the at.inc/ brand. By its own account it has made 58 investments with 12 exits, one IPO and four unicorns, including Netlify, HoneyBook and Placer.ai. Notable recent deals include leading Bagel AI's $5.5M seed in April 2025, a $3.0M seed in Podqi in March 2025, HelloCity's $585K pre-seed in 2024 and Stack's seed round in 2024. Early signature wins include leading Netlify's $2.1M seed in 2016 alongside the founders of GitHub, Heroku and Rackspace. at.inc/ specializes in being the very first institutional partner to technical founders.

ATA Ventures is a Redwood City, California-based venture capital firm founded in 2003 by Hatch Graham and Pete Thomas, with over $450 million of capital under management. The firm focuses on digital delivery platforms that empower business and consumer applications — specifically, investments where long-standing, outdated procedures can be replaced with technology-rich solutions. The founding partners bring decades of proven operating experience to portfolio companies, complementing capital with strategic guidance from people who have built technology businesses themselves. ATA leads rounds and deploys $1 million to $10 million at seed and Series A stages, with a portfolio concentrated in enterprise SaaS, software, B2B platforms, and data analytics. With 119 investments and 24 exits, the firm has a track record spanning over two decades across multiple enterprise technology cycles. Top portfolio areas include enterprise applications (18 investments) and enterprise infrastructure (9 investments), with the firm located at 203 Redwood Shores Parkway in the heart of Silicon Valley. Graham and Thomas built ATA around a clear operating philosophy: the best venture returns come from backing companies solving genuine enterprise inefficiencies, and the best support an investor can offer is operational experience — not just pattern recognition from watching other companies. The firm's proximity to major technology companies in the Bay Area, combined with more than twenty years of ecosystem relationships, provides portfolio companies with access to potential partners, customers, and talent throughout their growth trajectories.

Atacama Ventures is an early-stage venture capital firm founded in 2017, headquartered in the United States, with a strong focus on supporting disruptive technology startups. Their primary investment focus includes sectors such as microelectronics, information technology, automotive, renewable energy, semiconductors, and healthcare. Atacama Ventures aims to help startups scale globally by leveraging their team's deep expertise in both Silicon Valley and Brazilian markets. The firm prides itself on identifying bold thinkers and innovative leaders who can drive significant change. Atacama Ventures provides more than just capital, offering services like investor networking, talent sourcing, and strategic business consulting to help startups grow and succeed in competitive markets. The firm’s portfolio features diverse companies such as MoonPay, Flexe, and Daybreak Health, demonstrating their wide-ranging interest in sectors from fintech to healthtech. The team's operational experience across various industries helps startups transform into large-scale companies capable of competing on a global stage. With a focus on high-tech solutions, Atacama Ventures remains dedicated to fostering innovation that addresses global trends like big data analytics, climate change, and the rising costs of healthcare.

Atanova Ventures is an Izmir, Turkey-based early-stage venture capital firm founded in 2018. Operating from outside Istanbul, the firm takes a deliberate Turkey-centric approach, backing founders at the earliest incubation phases — often when ideas are still forming — across the growing Turkish tech ecosystem. Atanova leads rounds with checks typically between $100,000 and $500,000, targeting pre-seed and seed-stage companies. The firm has invested in 11 companies, with two portfolio exits through acquisition. Originally active across fintech, marketplaces, gaming, proptech, health, energy, and education, Atanova made a decisive strategic pivot in late 2023, narrowing its focus entirely to gaming and artificial intelligence. That concentration reflects the firm's conviction that these two sectors offer the most compelling near-term opportunity in the Turkish market. Atanova's investment philosophy centers on backing people rather than purely financial outcomes, emphasizing lasting relationships built on trust and shared ambition. The firm is willing to engage before conventional milestones exist, differentiating itself by supporting founders at the incubation stage when capital is scarce and operational guidance matters most. With a lean team embedded in Izmir, Atanova brings a local perspective to a national market that remains underserved relative to Istanbul-focused investors.

Ataraxia VC is a global venture capital firm managing multiple funds, including the Social Starts and Joyance Partners funds, which focus on early-stage investments in health, happiness, and well-being. Ataraxia typically operates at the pre-seed and seed stages, with follow-on investments up to Series A. They target sectors like biotech, neuroscience, precision health, femtech, and next-gen food technologies. Their portfolio includes over 250 companies globally, with a strong focus on science-driven, transformative opportunities. The firm's strategy emphasizes investments in innovative companies that align with its vision of improving health and happiness through technology. With funds spread across the US and Europe, Ataraxia provides both capital and strategic guidance to help startups scale rapidly. They prioritize founders with groundbreaking solutions, especially in consumer tech, wellness, and sustainability-focused sectors. Key team members include Mike Edelhart, a seasoned investor with decades of experience, and Holly Jacobus, an investment partner with a focus on femtech, farmtech, and sustainable manufacturing. Ataraxia’s approach is hands-on, often providing mentorship and guidance through every stage of a startup’s journey​.

Ataria Ventures is a Peru-based venture capital firm founded in 2017 by Managing Partners Alejandro Ponce and JP Ortiz, headquartered in San Isidro, Lima. The firm serves as a structured gateway for Latin American investors and corporations to engage with the world's leading technology ecosystems, combining direct venture investment with corporate venture building. It has completed more than 50 deals, with a direct portfolio of 15-plus companies and a broader network of over 40 companies worldwide. Ataria invests primarily at seed and Series A stages, with checks ranging from $100,000 to $2 million, across artificial intelligence, big data, agritech, foodtech, consumer, and health sectors in Latin America and the United States. Notable portfolio companies include Beam and GoTrendier. The founding partners bring backgrounds in venture investing, private equity, and digital transformation — a combination that positions the firm to bridge Latin American capital with global technology opportunities. The firm's core differentiation is its Corporate Venture Capital and Venture Building model, which offers Latin American corporates a structured pathway into startup innovation without building in-house venture teams from scratch. By combining investment with co-creation of digital businesses, Ataria helps established corporations participate meaningfully in the technology ecosystem while providing portfolio founders with access to corporate distribution channels and regional scale.

Atelier Ventures, founded by Li Jin, is an early-stage venture capital firm focused on the "Passion Economy," a concept that promotes enabling individuals to monetize their unique talents, creativity, and knowledge. This shift reflects the growing trend of people transitioning away from traditional employment toward independent work that aligns with their personal passions. Li Jin, who previously worked at Andreessen Horowitz, launched Atelier Ventures to fund companies that help democratize access to entrepreneurship. The firm’s investment thesis revolves around empowering creators by providing them with the tools, platforms, and resources to turn their individuality into income. Atelier Ventures supports startups building solutions that reduce the barriers to entry for entrepreneurship, including fintech platforms, SaaS tools, and educational services. These platforms facilitate the creation, distribution, and monetization of content, whether through podcasting, e-commerce, or other creative fields. Atelier Ventures focuses on businesses that promote independence while fostering community and collaboration among creators. Atelier’s portfolio includes companies that are reshaping the future of work by making it easier for creators to build and scale businesses. The firm envisions a future where creators, freelancers, and solopreneurs can collaborate in trusted networks and thrive in the digital age. This vision aligns with Li Jin's mission to support founders who challenge the status quo and create new, fulfilling work opportunities in the evolving digital landscape.

Atento Capital is a Tulsa-based venture capital firm founded with the mission of supporting early-stage tech startups, particularly those in underinvested communities. The firm was launched with backing from the George Kaiser Family Foundation, focusing on generating both market returns and social impact by funding innovative companies in the Heartland region of the U.S. Atento primarily invests in seed and early-stage companies, with check sizes ranging from $250,000 to $3 million. They are committed to fostering diversity in entrepreneurship, directing nearly half of their capital to underrepresented founders, including women and founders of color. Notable portfolio companies include RobbieAI, a platform using computer vision to prevent patient injuries, and PatchRx, a health tech solution aimed at improving medication adherence​. Beyond funding, Atento provides hands-on support to startups by offering mentorship, business development guidance, and access to local talent via partnerships with organizations like inTulsa. Their approach is deeply rooted in building long-term success for founders who have traditionally been overlooked by the broader venture capital ecosystem.

Atinum Investment, the venture capital arm of Atinum Partners, is a prominent South Korean investment firm with over $450 million in assets under management. The firm focuses on diverse sectors such as deep tech, artificial intelligence, blockchain, advanced robotics, bio-healthcare, and IT components. They actively invest in early-stage to growth-stage startups with significant global market potential. Notable portfolio companies include CryptoQuant, Allganize, and Klook. Atinum Investment has a global reach, particularly focusing on Southeast Asia, with investments in companies like InstaReM and Fast Five, a South Korean co-working space startup. The team at Atinum Investment includes key figures such as Wan Gee Cho, who specializes in deep tech and SaaS investments, and Peter Na, the Regional Head for Southeast Asia, focusing on investments in the region from the Singapore office. Atinum is committed to providing more than just capital by offering strategic guidance and opening doors to potential customers and partners, ensuring the growth and success of their portfolio companies.

Atland Ventures is a unique, student-run venture capital firm based in Minneapolis, Minnesota. Founded in 2015, Atland Ventures operates as a fully independent VC fund managed by University of Minnesota students. The firm primarily focuses on pre-seed and seed-stage investments, targeting technology-driven companies that address problems relevant to Generation Z. Atland is industry-agnostic, with a portfolio spanning sectors like edtech, fintech, AI, and consumer products. The firm's investment strategy emphasizes backing early-stage startups with validated product-market fit and potential for large-scale impact. Atland Ventures offers its portfolio companies not only capital but also access to a deep network of advisors, investors, and business leaders, particularly within the Twin Cities' entrepreneurial ecosystem. Their typical check sizes range between $25,000 and $50,000. Led by a diverse team of students from various academic backgrounds, Atland Ventures has built a strong portfolio that includes companies like Knit, Availyst, and Structural. The firm has completed several successful exits and continues to expand its reach within the venture ecosystem.

Atlanta Ventures is an Atlanta, Georgia-based venture capital firm and startup studio founded in 2012 by David Cummings, a serial entrepreneur who built and sold 10 companies, including Pardot (acquired by ExactTarget and subsequently Salesforce). The firm focuses exclusively on fast-growing SaaS and subscription businesses in the Southeast, targeting companies with under $5 million in ARR where founder-led capital and operational support can have the greatest impact. The firm leads or fills entire rounds with investments of $250,000 to $5 million across seed through Series B stages, having backed over 25 companies. Cummings's portfolio includes some of Atlanta's most consequential technology outcomes: Craig Hyde at Rigor, Kyle Porter at SalesLoft, Eric Spett at Terminus, and Tope Awotona at Calendly — which became a $3 billion-plus unicorn. Atlanta Ventures also runs a Studio program that systematically co-founds and scales subscription businesses by pairing proven methodology with experienced operators. The firm's differentiation is its founder-operator DNA. Cummings built the Atlanta Tech Village — one of the Southeast's largest tech hubs — and integrates community, content, and capital into a comprehensive ecosystem for regional entrepreneurs. That combination of hands-on operational experience, SaaS expertise, and deep local networks makes Atlanta Ventures the anchor early-stage institution for the Southeast tech corridor.

Atlantic Bridge, founded in 2004, is a global growth equity technology firm that focuses on investing in deep technology companies across Europe, the UK, and the US. With over €1 billion in assets under management, the firm has a portfolio of 70 companies and has created over 5,000 jobs. Atlantic Bridge is known for its cross-border value-add strategy, helping portfolio companies expand internationally through its offices in Dublin, London, Munich, Paris, and Palo Alto. The firm's portfolio includes notable companies such as SOC Prime, which specializes in enterprise threat detection and response, and Elisity, which combines Zero Trust Network Access with an AI-enabled Software Defined Perimeter. Other significant investments include Siren, an investigative intelligence platform, and Aizon, which optimizes pharmaceutical manufacturing processes using real-time data and predictive models. Atlantic Bridge has achieved successful exits with companies like Navitas Semiconductor, which recently debuted its GaN Power ICs on Nasdaq, and Mitiga, a provider of hybrid managed services for incident response and readiness. The firm is led by experienced industry professionals, including Managing Partners Elaine Coughlan, Brian Long, and Kevin Dillon, who bring extensive expertise in scaling technology companies and executing successful IPOs and M&As.

FoodLabs, founded in 2015 and based in Berlin, Germany, is a prominent venture capital firm dedicated to investing in innovative startups within the food, health, and sustainability sectors. The firm supports companies aiming to revolutionize how we produce, consume, and think about food, with a mission to create sustainable and healthy solutions for the future. FoodLabs has made a significant impact with its diverse portfolio, which includes companies like ChefCoco, a personalized weekly menu service, and Van Heron Labs, which focuses on biotechnology. The firm has been an early investor in some of the most influential European FoodTech startups, such as Infarm, Meatable, Mushlabs, and Sanity Group. These investments span across various stages, from pre-seed to series B and beyond, demonstrating FoodLabs' commitment to nurturing startups through their growth journey. The team at FoodLabs, led by founder Christophe Maire and managing director Patrick Noller, combines deep industry expertise with a strong network to provide strategic support and resources to their portfolio companies. They are particularly focused on sectors like synthetic biology, climate resilience, and health, aiming to address some of the world's most pressing challenges.

Atlantic Labs, based in Berlin, is a prominent early-stage venture capital firm that supports mission-driven founders across Europe. Founded in 2013, the firm has a focus on investing in transformative technology sectors such as climate tech, digital health, future of work, AI and data, industrial automation, mobility and logistics, fintech, and proptech. Atlantic Labs typically invests at the pre-seed stage, with investment sizes ranging from €25,000 to €5 million or more. They have backed over 215 companies, including notable names like SoundCloud, GetYourGuide, Clue, Vimcar, and Cazoo. The firm emphasizes a hands-on approach, providing not only capital but also strategic guidance and access to a robust network of industry experts to help their portfolio companies grow and succeed. The firm's portfolio reflects its diverse focus areas, supporting companies that aim to redefine various industries through innovative solutions. Examples include digital health companies like Clue, AI and data startups such as Mobius Labs, and mobility ventures like GetYourGuide and Cazoo. Atlantic Labs is led by a team of experienced investors and operators who are committed to supporting entrepreneurs throughout their entire journey. This commitment to fostering innovation and growth has established Atlantic Labs as a key player in the European venture capital landscape.

Atlantic Vantage Point (AVP), based in Paris, is an independent global investment platform with more than $2.7 billion in assets under management. Originally founded in 2016 as the corporate venture capital arm of AXA — one of the world's largest insurance groups — the firm completed a management buyout from AXA in 2024 to become a fully independent entity, with AXA remaining as an anchor limited partner. AVP leads rounds across Europe and North America, deploying from its flagship €1.5 billion AVP Growth I fund. The firm has made 94 investments across enterprise software, fintech, insurtech, digital health, and cybersecurity, backing businesses from early growth through to late stage. With typical checks ranging from $10 million to $100 million, AVP operates as a transatlantic platform combining deep local expertise in both European and North American markets. Its heritage in insurance and financial services provides portfolio companies with a distinctive strategic lens and access to industry relationships built over years within the AXA ecosystem. AVP's investment approach emphasizes strategic guidance alongside capital, leveraging its position at the intersection of European and US technology markets to help portfolio companies scale across both geographies. The firm's scale, sector expertise, and ability to support companies across multiple funding rounds distinguish it from single-geography growth investors. Its 2024 independence marks a new phase — one defined by broader LP relationships while retaining the institutional depth of its AXA origins.

Atlantis Ventures is a Munich, Germany-based pre-seed and seed stage venture capital firm founded in 2021. The firm invests in tech and software companies across the DACH region, the Nordics, and the United Kingdom, with a particular focus on SaaS, deep tech, and sustainability. Operating with a cross-border team split between Germany and India, the firm gives portfolio companies access to both European and South Asian markets and talent pools. Since its founding, Atlantis has invested in 22 companies, with active deployment continuing — including one new deal in the most recent 12 months. Checks range from under $100,000 to $500,000, targeting outlier founding teams at the earliest stage of company formation. The firm has built a portfolio spanning software, AI, and climate-focused ventures, reflecting the intersection of technology and impact that defines its thesis. Atlantis Ventures operates with a team-first investment philosophy, summarized by its tagline "Building the future, one extraordinary team at a time." Rather than filtering primarily by market size or product maturity, the firm prioritizes the quality, ambition, and composition of founding teams. This approach reflects a conviction that exceptional people building in important categories produce durable outcomes, and that the pre-seed stage is precisely where investor support creates the most leverage. The firm's lean structure keeps it close to founders throughout the earliest formative period.

Atlas Venture is a leading biotech venture capital firm focused on creating and building innovative life science companies. With over 30 years of experience, they have incubated over 70 startups and taken 40 companies public, including Intellia Therapeutics, Kymera Therapeutics, and Generation Bio. Atlas specializes in drug discovery and development, emphasizing areas like gene editing, oncology, and immunotherapy. Headquartered in Cambridge, Massachusetts, Atlas primarily targets U.S.-based startups but maintains a global vision, partnering with top scientific minds. They invest early, often leading seed and Series A rounds, with typical check sizes ranging from $5M to $20M. Atlas's approach is hands-on, actively incubating new ventures and co-founding companies with a strong operational focus. Key figures include Jean-François Formela, who has been instrumental in several high-profile exits and IPOs, and focuses on cutting-edge drug discovery technologies. Founders approaching Atlas should focus on breakthrough science with clear therapeutic applications, as the firm seeks to translate groundbreaking research into life-changing medicines.

Atlas Venture is a leading venture capital firm specializing in early-stage investments in biotechnology and life sciences. Founded in 1980 and based in Cambridge, Massachusetts, Atlas Venture has built a robust portfolio by focusing on groundbreaking biotech innovations. The firm has raised multiple funds, including their most recent Fund XIII at $450 million, which emphasizes their commitment to fueling biotech startups from seed stage through to successful exits​. Notable investments in their portfolio include companies like Intellia Therapeutics, Kymera Therapeutics, and Ikena Oncology. These investments highlight Atlas Venture's dedication to developing therapies that address significant unmet medical needs, particularly in oncology and genetic disorders. Intellia Therapeutics, for instance, is renowned for its gene-editing technologies, while Kymera Therapeutics focuses on protein degradation to treat diseases. Atlas Venture has achieved numerous successful exits, such as the acquisitions of IFM Therapeutics by Bristol-Myers Squibb and Novartis, and the IPO of Generation Bio. These exits underscore the firm’s strategic capability in identifying and nurturing high-potential biotech startups to maturity. The firm is led by a team of experienced partners, including Jean-Francois Formela, Jason Rhodes, and David Grayzel, who bring a wealth of expertise in venture capital and life sciences. This team collaborates closely with entrepreneurs to provide not just capital but also strategic guidance and operational support, leveraging their extensive network within the biotech industry. For startups aiming to partner with Atlas Venture, it is crucial to present innovative solutions with strong scientific foundations and clear pathways to address significant medical challenges. The firm values startups that demonstrate potential for substantial clinical impact and scalability within the healthcare sector.

AtmosClear Investments is a Lausanne-based venture capital firm dedicated to accelerating the clean-tech revolution by investing in disruptive technologies that drive sustainability. Established in 2001, AtmosClear focuses on sectors like renewable energy, water purification, sustainable agriculture, and smart city infrastructure. Their diverse portfolio includes companies working on innovative solutions such as large-scale solar and wind energy projects, energy storage, recycling systems, and biofuels, with investments across Europe, particularly the UK and Switzerland. One of their notable ventures is Close the Loop, a recycling company specializing in repurposing ink cartridges, and they have also managed major solar installations in the UK, totaling over 30 MW. The firm’s mission is to generate both financial returns and positive environmental impact, emphasizing the reduction of harmful pollutants like microplastics and greenhouse gases. They support companies at various stages, from early startups to more mature businesses in need of growth capital​. AtmosClear’s team is led by experienced professionals with decades of expertise in finance and private markets. Founder Henry Sykes and his team leverage their deep knowledge to identify opportunities that align with their sustainability ethos. The firm’s global reach is underscored by investments in multiple continents, and they continue to seek out promising clean-tech entrepreneurs who share their vision of a more sustainable future. With a strong emphasis on long-term ecological benefits, AtmosClear is setting a new standard for responsible, impactful investing in the clean-tech space.

Atomico, founded in 2006 by Skype co-founder Niklas Zennström, is a leading venture capital firm based in London, with additional offices in Paris, Berlin, and Stockholm. The firm focuses on Series A and beyond investments in disruptive technology companies globally. Atomico's notable investments include Klarna, Truecaller, Lime, Hinge Health, and Rovio, which highlight their strong presence in fintech, healthcare, consumer tech, and gaming sectors. Atomico's investment strategy centers around partnering with mission-driven European founders, providing them with not just capital but also extensive operational support through their Growth Acceleration Team. This team assists with scaling operations, strategic planning, and navigating complex market dynamics. Their typical investment range is from $10 million to $50 million, and they often lead rounds, ensuring significant influence in their portfolio companies' trajectories. The firm is known for its diverse team and deep industry expertise. Key figures include Niklas Zennström, CEO and Partner; Chris Barnes, COO; and Thomas Wehmeier, Partner and Head of Insights, all based in London. This diverse leadership team brings a wealth of experience from various sectors, enhancing their ability to support and scale innovative startups. For startups looking to engage with Atomico, it's crucial to showcase innovative solutions with a potential for significant market impact. The firm is particularly interested in technology-driven companies that can leverage shifts in consumer behavior and technological advancements.

Atooro Fund is a venture capital firm based in Tel Aviv, Israel, established in 2016. It focuses on investing in seed, early-stage, growth-stage, and later-stage companies. The fund primarily targets sectors such as information technology, cybersecurity, food technology, agricultural technology, artificial intelligence, and machine learning. The fund supports innovative entrepreneurs and helps them build global companies. Atooro Fund’s investment strategy involves backing startups that bring significant advancements in their respective fields. Notable investments include Beewise, which specializes in autonomous beehive technology, QuantHealth, and Wisor AI, which operates in the AI and machine learning domains. The firm is led by Jacob Engel, who serves as the Chairman, and Yonatan Brender, the General Managing Partner. Engel is known for his extensive background in various industries, including mining and real estate, while Brender brings a wealth of experience in venture capital and technology investments. Atooro Fund aims to foster innovation and growth by providing not only financial support but also strategic guidance and resources to its portfolio companies, ensuring they can navigate challenges and achieve sustainable growth.

ATP Fund, established in 2014 and headquartered in Austin, Texas, is an early-stage venture capital firm that focuses on deep tech investments aimed at advancing human conditions through scientific innovation. The firm specializes in sectors such as artificial intelligence (AI), biotechnology, cleantech, cybersecurity, enterprise software, healthcare, and robotics. ATP Fund is known for its strategic investments in startups that are tackling some of the most challenging and impactful problems of our time. ATP Fund adopts a contrarian and hands-on approach, often partnering with scientific entrepreneurs at the earliest stages of their ventures, sometimes even at the formation stage via their Proto.n initiative. This strategy reflects their commitment to long-term partnerships and their belief in the transformative potential of cutting-edge technologies. The fund's portfolio includes a variety of high-impact companies like Diligent Robotics, which focuses on healthcare robotics, and Infleqtion, a firm that specializes in quantum technology. These investments highlight ATP Fund's dedication to supporting ventures that have the potential to make significant advancements in their respective fields. ATP Fund collaborates with a wide network of co-investors, including notable names like Texas Venture Labs and Osage University Partners. The firm has also seen successful exits, further establishing its reputation as a key player in the deep tech investment landscape.

Atria Ventures is a San Francisco-based venture capital firm founded in 2023 by General Partner Chris Leiter. The firm invests at the intersection of life sciences and artificial intelligence, partnering with founders working at the edges of biology and human health to reimagine the trillion-dollar life sciences industry from molecule to patient. Atria leads rounds at pre-seed and seed stages, with a sweet spot of $800,000 and a range of $250,000 to $2 million. Through its closed Fund I, Atria has made 15 investments across healthcare AI, biotech, and clinical development. Notable portfolio companies include Sleuth Insights in healthcare analytics, Peer AI in healthcare artificial intelligence, and Trially in clinical trials technology. The most recent investment was in Peer AI's Series A in October 2025, reflecting the firm's commitment to following its strongest portfolio companies into later rounds. Atria differentiates itself through singular focus on the convergence of computational approaches and life sciences — a sector where AI is fundamentally transforming drug discovery, diagnostics, clinical trials, and patient care delivery. Rather than investing broadly across healthcare, the firm concentrates on companies where deep learning, biological data, and clinical insight create compounding advantages. Chris Leiter's background informs a hands-on, thesis-driven approach that prioritizes founders working on problems with both scientific novelty and clear paths to clinical or commercial adoption.

ATX Seed Ventures, now operating as ATX Venture Partners, is an Austin, Texas-based early-stage venture capital firm founded in 2014 by Brad Bentz, Danielle Weiss Allen, and Chris Shonk. The firm manages more than $60 million in assets, including a $32 million second fund raised in 2019, and focuses on leading seed and Series A investments in disruptive B2B software, APIs, applications, frontier tech, and marketplaces. It leads rounds with checks averaging $2.5 million, up to $5 million per investment. ATX has invested in 26-plus companies and established itself as one of the most active early-stage funds in the Texas technology ecosystem. Notable portfolio companies include Alert Media, SourceDay, GoCo, LIFT Aircraft, Pensa Systems, QuotaPath, Slingshot Aerospace, and monoDrive — representing the breadth of its coverage across supply chain, fintech, insurtech, and frontier tech sectors. Limited partners include successful entrepreneurs, executives, institutions, and family offices. The firm rebranded from ATX Seed Ventures to ATX Venture Partners in 2019 to reflect expanded scope beyond strictly seed-stage investing. Its geographic concentration in Austin — one of the fastest-growing technology hubs in the United States — gives the team deep local relationships and access to deal flow that coastal funds often miss. The founding partners bring complementary operational and investing backgrounds, enabling hands-on support for portfolio companies navigating product development, go-to-market, and early scaling challenges.

Atypical Ventures is a venture capital firm founded by Ruby Lu in 2019, focusing on early-stage technology companies. The firm has a global presence with offices in the United States and China, investing in sectors such as high-tech, environment tech, and enterprise applications. Atypical Ventures has a strong emphasis on supporting engineers who are solving foundational challenges in nascent markets. The firm’s portfolio includes companies like Buddy, an insurtech startup, and Norm Ai, which focuses on enterprise applications. Atypical tends to make seed and early-stage investments, with notable participation in rounds alongside co-investors like Coatue and DCVC. The firm is known for its hands-on approach, helping founders develop disruptive solutions that are shaping the future. Led by Ruby Lu and a small team of experienced professionals, Atypical Ventures is carving a niche in backing innovative tech solutions across the globe.

AU21 Capital is a venture capital firm focused on investing in blockchain technology. Founded in 2017, AU21 Capital combines decades of executive and operational experience from industry leaders like Huobi and Galaxy Digital. The firm invests primarily in early-stage and seed investments, supporting companies that are pushing the boundaries of blockchain technology. AU21 Capital’s portfolio includes notable projects such as Axie Infinity, Injective, Marlin, Cere, Covalent, Casper Labs, Serum, Fantom, Harmony, Iotex, Coin98, Polkadot, and Star Atlas. The firm is known for its deep involvement in the development and growth of these companies, often collaborating with top exchanges and launchpads to bring innovative products to market. The leadership team at AU21 Capital leverages its extensive network and expertise to provide strategic guidance, business development, and market positioning for its portfolio companies. This hands-on approach ensures that the startups they back are well-equipped to navigate the challenges of the blockchain industry and achieve significant growth.

AUBE Management is an independent venture capital firm based in Champs-sur-Marne, France, founded in 2018. The firm specializes in sustainable development, energy, and new technologies, focusing on supporting innovative small and medium enterprises (SMEs) with high growth potential. AUBE Management takes minority stakes in these companies, helping accelerate their growth over an investment horizon of about five years. The firm prides itself on its strong entrepreneurial culture, providing hands-on management support to help businesses scale both in France and internationally. AUBE Management is led by Nicolas Aubé, the founder and CEO, who has a background in telecoms and founded CELESTE, an internet service provider for businesses. The team also includes Jean-Yves Aubé as Investment Director and Nathalie Batista as Executive Assistant. AUBE Management’s portfolio includes companies such as CERBAIR, specializing in anti-drone technology, and NFINITE, a visual creation platform revolutionizing the e-commerce space. They focus on industries with sustainable growth models, targeting firms that have already achieved initial commercial success.

AUC Venture Lab (V-Lab) is Egypt's first university-based startup accelerator, launched in 2013 by the American University in Cairo as part of the Onsi Sawiris School of Business. Operating in Cairo, V-Lab has a dual mission: helping Egyptian startups commercialize innovative technologies into viable ventures that contribute to economic growth and job creation, while providing an entrepreneurship learning platform for the AUC community. Since launch, V-Lab has supported more than 1,000 entrepreneurs and incubated 115 startups. In its first five years alone, those companies generated EGP 88 million in revenues, raised more than EGP 220 million in investment, and created over 500 jobs. The flagship four-month program guides entrepreneurs through designing and scaling tech-enabled businesses while preparing for institutional investment — with checks at the pre-seed stage up to $100,000. In 2016, V-Lab launched a dedicated FinTech Accelerator Program in partnership with Commercial International Bank (CIB). Corporate partners include Arab African International Bank as co-founder, along with SODIC, Shell, and General Electric. V-Lab has received eight international awards recognizing its impact on the Egyptian and MENA entrepreneurship ecosystems. Its position within a leading regional university gives it a distinctive ability to connect early founders with academic networks, research infrastructure, and a growing alumni community. The accelerator has established itself as the anchor institution for tech-enabled startup formation in Egypt and a recognized model for university-affiliated venture programs across North Africa.